To accomplish our mission we need people who enjoy working in a dynamic...
 
 



Site map  

about novexel


overview

mission and strategy

management

history

investor relations

novexel's science


overview

discovery

market

pipeline


overview

NXL104

NXL103

preclinical

news and events


press releases

publications

videos

careers


overview

positions


Print this page

> Stachyra, T., Levasseur, P., PĂ©chereau, M-C., Girard, A-M., Claudon, M., Miossec C., Black M.T. In vitro activity of the beta-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases, Journal of Antimicrobial Chemotherapy (2009) 64 (2), 326-329.


> See all publications